Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs de...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94ff28ca65e5414195014839c12c40a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:94ff28ca65e5414195014839c12c40a0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:94ff28ca65e5414195014839c12c40a02021-12-02T14:16:48ZBurkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine10.1038/s41541-021-00281-z2059-0105https://doaj.org/article/94ff28ca65e5414195014839c12c40a02021-01-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00281-zhttps://doaj.org/toc/2059-0105Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4+, and CD8+ T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis.Sarah M. BakerErik W. SettlesChristopher DavittPatrick GellingsNicole KikendallJoseph HoffmannYihui WangJacob BitounKasi-Russell LodrigueJason W. SahlPaul KeimChad RoyJames McLachlanLisa A. MoriciNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Sarah M. Baker Erik W. Settles Christopher Davitt Patrick Gellings Nicole Kikendall Joseph Hoffmann Yihui Wang Jacob Bitoun Kasi-Russell Lodrigue Jason W. Sahl Paul Keim Chad Roy James McLachlan Lisa A. Morici Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
description |
Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4+, and CD8+ T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis. |
format |
article |
author |
Sarah M. Baker Erik W. Settles Christopher Davitt Patrick Gellings Nicole Kikendall Joseph Hoffmann Yihui Wang Jacob Bitoun Kasi-Russell Lodrigue Jason W. Sahl Paul Keim Chad Roy James McLachlan Lisa A. Morici |
author_facet |
Sarah M. Baker Erik W. Settles Christopher Davitt Patrick Gellings Nicole Kikendall Joseph Hoffmann Yihui Wang Jacob Bitoun Kasi-Russell Lodrigue Jason W. Sahl Paul Keim Chad Roy James McLachlan Lisa A. Morici |
author_sort |
Sarah M. Baker |
title |
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_short |
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_full |
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_fullStr |
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_full_unstemmed |
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_sort |
burkholderia pseudomallei omvs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/94ff28ca65e5414195014839c12c40a0 |
work_keys_str_mv |
AT sarahmbaker burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT erikwsettles burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT christopherdavitt burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT patrickgellings burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT nicolekikendall burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT josephhoffmann burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT yihuiwang burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT jacobbitoun burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT kasirusselllodrigue burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT jasonwsahl burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT paulkeim burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT chadroy burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT jamesmclachlan burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT lisaamorici burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine |
_version_ |
1718391682027749376 |